Evidence map›Paper›PMID 24581425›Full record

ArticleJournal of thrombosis and haemostasis : JTH2014

Cytohesin-2 phosphorylation by protein kinase C relieves the constitutive suppression of platelet dense granule secretion by ADP-ribosylation factor 6.

M T J van den Bosch, A W Poole, I Hers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Integrin αBlood · 2017
    Review
  10. In-depth PtdIns(3,4,5)PBlood advances · 2017
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M T J van den BoschSchool of Physiology and Pharmacology, University of Bristol, Bristol, UK.
A W Poole
I Hers
University of Bristol · GB

Funding

British Heart Foundation FS/11/62/28934British Heart Foundation FS/12/22/29510British Heart Foundation PG/12/79/29884British Heart Foundation PG/13/11/30016British Heart Foundation RG/10/006/28299
6 · The paper itself

Abstract

backgroundProtein kinase C (PKC) is a major regulator of platelet function and secretion. The underlying molecular pathway from PKC to secretion, however, is poorly understood. By a proteomics screen we identified the guanine nucleotide exchange factor cytohesin-2 as a candidate PKC substrate.

objectivesWe aimed to validate cytohesin-2 as a PKC substrate in platelets and to determine its role in granule secretion and other platelet responses. METHODS AND

resultsImmunoprecipitation was performed with a phosphoserine PKC substrate antibody followed by mass spectrometry, leading to the identification of cytohesin-2. By western blotting we showed that different agonists induced cytohesin-2 phosphorylation by PKC. Protein function was investigated using a pharmacological approach. The cytohesin inhibitor SecinH3 significantly enhanced platelet dense granule secretion and aggregation, as measured by lumi-aggregometry. Flow cytometry data indicate that α-granule release and integrin αII b β3 activation were not affected by cytohesin-2 inhibition. Lysosome secretion was assessed by a colorimetric assay and was also unchanged. As shown by western blotting, ARF6 interacted with cytohesin-2 and was present in an active GTP-bound form under basal conditions. Upon platelet stimulation, this interaction was largely lost and ARF6 activation decreased, both of which could be rescued by PKC inhibition.

conclusionsCytohesin-2 constitutively suppresses platelet dense granule secretion and aggregation by keeping ARF6 in a GTP-bound state. PKC-mediated phosphorylation of cytohesin-2 relieves this inhibitory effect, thereby promoting platelet secretion and aggregation.

Indexed as

ActinsAdenosine TriphosphateADP-Ribosylation Factor 6Animalsbeta-N-AcetylhexosaminidasesBlood PlateletsChromosomal Proteins, Non-HistoneFlow CytometryGTPase-Activating ProteinsGuanosine TriphosphateHumansImmunoprecipitationLysosomesMass SpectrometryMiceMice, KnockoutActinsACTR6 protein, humanAdenosine TriphosphateADP-Ribosylation Factor 6ARF6 protein, humanArf6 protein, mousebeta-N-AcetylhexosaminidasesChromosomal Proteins, Non-Histonecytohesin-2GTPase-Activating ProteinsGuanosine TriphosphatePlatelet Glycoprotein GPIIb-IIIa ComplexProtein Kinase CADP-ribosylation factor 6cytohesin-2plateletsprotein kinase Csecretion

Identifiers

PMID24581425
PMCPMC4238808
OpenAlexW2051506039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.